Abstract:During excitotoxicity, reactive oxygen species, produced by NADPH‐oxidase 2 (NOX‐2), increases the levels of aquaporin‐4 (AQP4) leading to the rupture of the blood–brain barrier and cerebral edema. This along with oxidative stress contributes to neuronal death. Stimulation of cannabinoid receptor type 1 receptors relieves oxidative stress by a reduction of NOX‐2 activity and thus inhibits AQP4 increase, edema, and brain damage. The endocannabinoid system can be a therapeutic target for limiting brain damage. Background Excitotoxicity is a process in which NADPH oxidase‐2 (NOX‐2) plays a pivotal role in the generation of reactive oxygen species (ROS). Oxidative stress influences the expression of Aquaporin 4 (AQP4), a water channel implicated in blood–brain barrier (BBB) permeability and edema formation. The endocannabinoid system is widely distributed in the brain, particularly through the cannabinoid receptor type 1 (CB1) and type 2 (CB2), which have been shown to have a neuroprotective function in brain injury. Given the significant involvement of NOX‐2 in ROS production during excitotoxicity, our research aims to assess the participation of NOX‐2 in the neuroprotective effect of the cannabinoid receptor agonist WIN55,212‐2 against glutamate‐induced excitotoxicity damage in the striatum using in vivo model. Methods Wild‐type mice (C57BL/6) and NOX‐2 KO (gp91Cybbtm1Din/J) were stereotactically injected in the striatum with monosodium glutamate or vehicle. Subsequently, a group of mice was administered an intraperitoneal dose of WIN55,212‐2, AM251, or AM251/WIN55,212‐2 following the intracerebral injection. Motor activity was assessed, and the lesion was examined through histological sections stained with cresyl violet. Additionally, brain water content and Evans blue assay were conducted. The activity of NOX was quantified, and the protein expression of CB1, gp91phox, AQP4, Iba‐1, TNF‐α, and NF‐κB was analyzed using Western blot. Furthermore, ROS formation was measured through the DHE assay. Results The activation of the endocannabinoid receptors demonstrated a neuroprotective response during excitotoxicity, meditated by NOX‐2. The reduction in ROS production led to a decrease in neuroinflammation, and AQP4 expression, resulting in reduced edema formation, and BBB permeability. Conclusions During excitotoxic damage, WIN55,212‐2 inhibits NOX‐2‐induced ROS production, reducing brain injury.

Protective Effects of Cannabidiol (CBD) against Qxidative Stress, but Not Excitotoxic-Related Neuronal Cell Damage—An In Vitro Study

A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors

Isobolographic Analysis of the Cytoprotective Effect of Dapsone and Cannabidiol Alone or Combination upon Oxygen–Glucose Deprivation/Reoxygenation Model in SH-SY5Y Cells

Cannabidiol effectively prevents oxidative stress and stabilizes hypoxia-inducible factor-1 alpha (HIF-1α) in an animal model of global hypoxia

Cannabidiol Toxicity Driven by Hydroxyquinone Formation

Cannabidiol Protects Striatal Neurons by Attenuating Endoplasmic Reticulum Stress

High Concentrations of Cannabidiol Induce Neurotoxicity in Neurosphere Culture System

Cannabidiol protects mouse hippocampal neurons from neurotoxicity induced by amyloid β-peptide 25–35

Investigation of neuroprotective and therapeutic effects of cannabidiol in an acute coronary syndrome model

Investigation of cannabidiol-induced cytotoxicity in human hepatic cells

Safety assessment and redox status in rats after chronic exposure to cannabidiol and cannabigerol

CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX‐2 Activity and Oxidative Stress

Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions

Antioxidative and Anti-Inflammatory Properties of Cannabidiol

Cannabidiol protects against Alzheimer's disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups

Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson’s disease

Neuroprotective Effects of Methyl Caffeate against Hydrogen Peroxide-Induced Cell Damage: Involvement of Caspase 3 and Cathepsin D Inhibition

Acute and chronic cannabidiol treatment: In vitro toxicological aspects on human oral cells

Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders

Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: Critical role of p38 MAPK activation

Sesquiterpene-evoked phytochemical toxicity in PC12 neuronal cells reveals a variable degree of oxidative stress and alpha-tocopherol and glutathione-dependent protection